TruthArchive.ai - Related Video Feed

Research conducted by Bruce Patterson at InCelDx reveals that spike proteins can remain in the body for extended periods. In severe COVID cases, the s one segment was found in white blood cells for up to 15 months after infection. Even after vaccination, the full-length spike protein, including the s one and s two segments, was detected in white blood cells for at least 9 months. Another study from Stanford, led by Roelkern and colleagues, discovered messenger RNA, the genetic code for the spike protein, in lymph nodes for up to 2 months. These findings suggest that both messenger RNA and spike proteins can persist in the human body for several months.

The speaker discusses the presence of ACE2 receptors in various sites of the body. They mention that the spike protein from the COVID-19 vaccine can circulate in the body for at least 2 weeks, possibly longer for those lacking the enzyme mRNA. The speaker also mentions cases of people dying after receiving the vaccine and emphasizes that the spike protein is the toxin. They criticize the idea that the vaccine couldn't be the cause of these deaths due to the time elapsed since vaccination, arguing that the toxin can still be circulating in the body.

The speaker confirms that the spike protein from the COVID-19 vaccine is produced in the deltoid muscles where it is injected. However, they also found the spike protein expressed in various organs, including the testes. In a 28-year-old man who died 140 days after vaccination, the spike protein was strongly expressed in the testes, leading to a decrease in spermatocytes. The same was observed in an older man. The speaker personally comments that if they were a woman of fertile age, they would be hesitant to plan motherhood with a vaccinated man due to these findings, which they find disturbing.

For biodistribution, Pfizer did not use the actual spike mRNA product in their studies. Instead, they substituted in a luciferase reporter mRNA packaged in the same lipid nanoparticles. This approach allowed them to track where the mRNA traveled in rodents. The studies showed that following intramuscular injection, most of the mRNA remained at the site of injection, but there was also notable levels detected in the liver. Despite the limitations of this approach, which can underestimate low level or transient distributions to other tissues, it nevertheless showed that the vaccine components do not remain confined to the injection site. Next slide. For Moderna, no dedicated biodistribution study was performed with the COVID mRNA itself. Instead, data was provided from a surrogate product, a CMV mRNA, mRNA-sixteen 47, which used the same lipid nanoparticle formulation. In their rat study, after intramuscular injections, high levels of the mRNA were detected at the injection site, but also in multiple organs such as the draining lymph nodes, spleen, eye, and liver. Lower levels were also found across a wide range of tissues, including the heart, lungs, testes, and brain. Importantly, this study clearly showed that the mRNA can cross the blood brain barrier. Next slide. Consistent with what is seen in animal studies, the vaccine mRNA and its spike protein have been detected in humans across multiple tissues, including blood, lymph nodes, the heart, and even the brain. These findings make it clear that the mRNA does not remain confined to the injection site. Importantly, persistence has been documented well beyond the initial hours or days, lasting weeks in some tissues, and in certain studies detectable for many months. Next slide. To summarize the biodistribution data, it's important to note that neither Moderna nor Pfizer used their actual commercial mRNA vaccine products in the preclinical biodistribution studies. Instead, they relied on surrogate construct packaged in same or similar lipid nanoparticles. Second, the results of those studies show that the mRNA and lipid nanoparticles were not confined to the injection site. Systemic distribution was observed with evidence that the mRNA can cross the blood brain barrier. Consistent with these findings, studies in humans have confirmed that vaccine mRNA can be detected in multiple tissues, including lymph nodes, the heart, the central nervous system, and blood. Finally, persistence is not just short term. In some reports, mRNA has been detected for weeks to months, and in certain cases as long as seven zero six days post vaccination. Taken together, these data highlight that biodistribution is broad and persistence is longer than initially expected, raising important questions and concerns for ongoing research and safety monitoring.

In a deceased patient, spike protein was found in the heart but not nucleocapsid protein. The autopsy revealed bronchopneumonia, Parkinson's disease, necrotic encephalitis, and myocarditis. The author suggests that the spike protein in affected tissues was likely from gene-based COVID-19 vaccines, not a SARS CoV-2 infection, as nucleocapsid protein was absent. Spike protein was found in areas with brain and heart inflammation, possibly contributing to the disease.

The speaker presents findings that show the spike protein, present in COVID-19 vaccines, is produced not only in the deltoid muscles where the vaccine is injected, but also in various organs. They provide examples of a 28-year-old man and an elderly man, both showing strong expression of the spike protein in the testes. The images reveal a decrease in spermatocytes and an increase in spike protein expression in the testicular tissue. The speaker concludes with a personal comment, expressing their disturbance by the images shown.

Cette vidéo résume: selon Nakaoota et al. (3 avril 2025), « l’expression de la protéine Spike chez 43.8 pour 100 des personnes vaccinées anti Covid » persiste « au niveau des artères coronaires » jusqu’à 17 mois après l’injection, avec « l’ARN messager, du vaccin, mais également du virus » détecté. Il y a « persistance de la protéine Spike » et « persistance du SARS-CoV-2 » possiblement malgré les traitements précoces. L’auteure mentionne aussi « Crüssfeld Jacob, 14 mois après infection » et une étude sur des « AVC 17 mois après injections ». L’interaction de la nucléocapside (protéine N) avec TRIM28 pourrait retarder la réponse immunitaire innée, renforçant la tolérance immunitaire via TLR2/RAGE et IgG4. Conséquences: infection potentiellement asymptomatique et dégâts cumulatifs; Spike persistante pourrait entraîner « spike viral plus spike vaccinal ». Des spycopathies neurologiques sont évoquées; dépistage de Spike et traque du virus recommandés; traitements personnalisés et soutien par curcumine, quercétine, vitamine D; approche individuelle. This video summarizes: according to Nakaoota et al. (April 3, 2025), « the expression of the spike protein in 43.8 per 100 of vaccinated people » persists « at the level of the coronary arteries » for up to 17 months after injection, with « mRNA from the vaccine, but also the virus » detected. There is « persistence of the Spike protein » and « persistence of SARS-CoV-2 » possibly despite early treatments. The author also cites « Crüssfeld Jacob, 14 months after infection » and a study on « strokes 17 months after injections ». The interaction of the nucleocapsid protein (N) with TRIM28 could delay the innate antiviral response, reinforcing immune tolerance via TLR2/RAGE and IgG4. Consequences: potentially asymptomatic infection and cumulative damage; persistent Spike could lead to « spike viral plus spike vaccinal ». Neurological spycopathies are discussed; diagnostics to detect Spike and tracking the virus are recommended; therapies to block/remove Spike and personalized approaches, with supports like curcumin, quercetin, vitamin D.

Recent studies indicate the persistence of spike protein in the body long after the initial introduction. A Yale study detected it 709 days out, while a Patterson study found it 245 days out. This extended presence is unusual, as most proteins have a turnover rate of weeks, not years. This suggests either the spike protein is being continuously regenerated within the body or it is somehow evading destruction for extended periods in bodily reservoirs. This leads to speculation that the mRNA may be lasting longer than expected or that plasmids are still present and generating spike protein. The exact mechanism behind this phenomenon is currently unknown.

Speaker 0 lays out a numerical comparison between vaccine versus infection to determine which creates more spike proteins, according to the source material. First, the infection scenario. The unit counted is the virion (one complete virus particle). At the peak of infection, the body could be fighting off somewhere between one to 100,000,000,000 virions. Each virion has spike proteins on its surface, counted as between twenty five and fifty spikes per virion. The calculation multiplies the range of virions by the spikes per virion, giving a peak infection spike protein load of two to 10,000,000,000,000 spike proteins. Next, the vaccination scenario. The math starts with modified messenger RNA (modRNA) molecules in a vaccine dose. A single vaccine dose contains somewhere between 14 to 42,000,000,000,000 modRNA molecules. Each of these trillions of modRNA molecules can produce multiple spike proteins, ranging from 10 to 1,000 each. When the numbers are multiplied, the source calculates a potential total of up to 100,000,000,000,000,000 spike proteins (up to 10^17, i.e., up to one hundred quadrillion). Speaker 0 then contrasts the two scenarios. In a side-by-side view, the initial particles are billions of virions versus trillions of modRNA molecules. The timing differs as well: a natural infection builds up over about a week, whereas the vaccine dose is delivered all at once, in just a few seconds. The final totals are two to 10,000,000,000,000 spikes from infection versus a potential of up to one hundred quadrillion from vaccination. Visually, this difference is stark, with the infection spike protein bar being far smaller than the vaccine spike protein bar, illustrating an order-of-magnitude difference. The discussion then moves to the distribution and persistence of spike proteins. The source describes the virus's spread as more localized or comparatively narrow, while vaccine components are said to travel throughout the entire body, with accumulation in areas including major organs like the heart and the brain, and the potential to cross barriers such as the blood-brain barrier and the placental barrier. Regarding duration, spike mRNA was reportedly detected in cerebral arteries after seventeen months, and some vaccinated individuals were reportedly still spike positive for up to sixteen hundred days. The source concludes, “Your spike load is orders of magnitude higher via injection.” Speaker 0 notes that the numbers show trillions versus quadrillions and emphasizes the presented math and its implications as the core of the comparison, while acknowledging the source’s look at spike proteins’ distribution and persistence.

The speaker observed vasculitis, or inflammation of the blood vessels, in the brain tissue of almost all cases examined post-vaccination. Lymphocytes aggregate around small vessels, indicating inflammation possibly triggered by an antigenic structure like spike protein. This was described as one of the most alarming findings. Individuals with this complication may experience transient defects like loss of speech, unconsciousness, or blindness, but the brain can compensate if there is no major inflammation or hemorrhage. The speaker clarified that the individuals did not die from the vasculitis itself. It's possible for vaccinated individuals to experience these symptoms without knowing the underlying cause. Changes in character have been reported in some vaccinated individuals, which may be related to this inflammation.

The spike protein, according to research in South Africa, induces fibrin from fibrinogen, forming the backbone of clotting in a way not previously seen. Unlike normal fibrin clots that are easily broken down, clots formed from COVID or the spike protein from the vaccine are difficult to break down, causing issues for many people. A cardiologist stated that in their decades of practice, they have never treated as many blood clots as in the last five years. These blood clots occur after the virus infection and the vaccine because the spike protein causes blood clots. Therefore, it is reckless to continue vaccinating people and loading the body with spike protein, causing more blood clots. According to a paper in Cell (July 2021), the nucleoprotein, not the spike protein, supplied broad and durable immunity for the prevention of infection. The speaker questions why the vaccine wasn't changed to target the nucleoprotein once this information came to light.

Spike is a toxin that can cross the blood-brain barrier, causing disruption to the brain's blood vessels and leading to inflammation. This inflammation is responsible for the brain fog experienced by both COVID patients and those who have been vaccinated. Despite claims that there have been no deaths or injuries from the vaccine, this is not true. The image shown reveals the presence of inflammation in the brain, indicated by the blue color. This inflammation is a result of the spike toxin.

The speaker discusses the inflammatory and amyloidogenic effects of small sequences called epitopes, which can cause memory dysfunction in mice. They also mention a study that found the introduction of gene transfection technologies containing the spike protein can induce amyloidogenic cascades. The speaker highlights a 200% increase in the diagnosis of CJD in France after the rollout of vaccination programs, suggesting a potential link. They discuss the loss of cognitive function associated with exposure to the spike protein and propose that amyloidogenic disease processes may underlie long-haul COVID-19 symptoms. The speaker mentions the role of viral infections in facilitating intercellular aggregate dissemination and shares examples of misfolding prion amyloidogenic diseases.

A colon biopsy from a Pfizer-vaccinated individual who died a month after tumor emergence revealed SV40 in the origin of replication from the Pfizer vaccine. Preliminary sequencing suggests the presence of Pfizer's vaccine. The vaccine DNA copy number was greater than the human genome, indicating replication. PCR signals suggest the vaccine concentration is similar to or higher than the original vial, despite dilution in the body. This indicates the mammalian origin of replication in Pfizer's vaccine is active in human tumors. This finding may explain shedding, which is not supposed to occur because the COVID vaccine is not intended to alter DNA. However, evidence suggests that the vaccine may be altering DNA, making it a VGBT (genome altering) product. This could mean that spike proteins are continually created, and shedding is real.

Speaker 0 describes what he claims is the strongest case report ever done on vaccine injury, specifically mRNA vaccine injury. The subject is a 51-year-old man who developed myocarditis, pulmonary embolism, neurological disturbances, and skin disturbances, constituting multisystem long vaccine syndrome. The key findings are said to be detected 3.6 years after his last shot. Exosomes circulating in his body allegedly contain Pfizer mRNA, and this mRNA is still present in those exosomes years after vaccination. The same mRNA is reportedly also found in his skin. In addition, plasmid DNA from the manufacturing process is claimed to be present in his skin, again 3.6 years after vaccination. Specifically, the plasmid DNA allegedly includes the SV40 segment, the spike expression cassette, and the open reading frame region, with all components of the plasmids in the Grover's disease–affected skin area. Microscopic analysis of the Grover’s disease area allegedly showed staining for SARS-CoV-2 spike or vaccine spike, indicating the presence of spike protein in that skin region. This staining for spike protein is reported as occurring 3.6 years after the shot. Overall, the speaker asserts that all vaccine components—mRNA, plasmid DNA with defined segments, and spike protein—remain in the body for multiple years, with findings in exosomes and skin indicating long-lasting presence. The speaker also asserts that this represents a situation in which “we were completely lied to.”

Professor Burkhard, a retired pathologist, conducted autopsies on COVID patients and post-COVID vaccine deaths. He found that over 80% of the autopsies showed a clear or likely association with the COVID vaccine. He also observed spikes in various organs, including the testicles, ovaries, and placenta. Strange elastic structures were formed in the blood of vaccinated individuals. Professor Burkhard called for independent investigations into COVID management and a halt to vaccinations due to increased excess mortality. Sadly, Professor Burkhard passed away recently, leaving behind a legacy as a leading voice in the field. The endothelium is the primary target of the vaccine, affecting all organs except teeth. The spike protein was found in most organs, particularly in the vessels.

The spike protein produced by the COVID-19 vaccine is found not only in the deltoid muscles where it is injected, but also in various organs. In a case study of a 28-year-old man who died 140 days after vaccination, the spike protein was strongly expressed in the testes, leading to a decrease in spermatocytes. Similar findings were observed in an older man. The speaker personally finds these findings disturbing and suggests that women of childbearing age should avoid planning motherhood with vaccinated men.

There's new evidence suggesting shedding might be real. The mRNA vaccines were called vaccines instead of gene therapy so they wouldn't have to test for shedding on non-injected people. We're giving your body the code to make the virus' spike protein, creating immunity. The spike protein alone won't kill you, but your body learns to eliminate it. If you later get COVID, your body will recognize and attack the spike protein. However, there's no guarantee your body stops producing the spike protein. Your cells, once healthy, now make spike proteins, which your immune system attacks, even if it's your own cells. The mRNA in the vaccines is stabilized to last longer and is coated in lipid nanoparticles to protect it and cross the blood-brain barrier.

The spike protein from the COVID-19 virus circulates in the body and can land in multiple organs, causing various diseases. Lab studies have shown that even without the virus, just injecting the spike protein can induce the same lung, vascular, heart, and brain diseases as COVID-19. The spike protein is considered the toxin responsible for causing the disease. This raises questions about why we are injecting something that is essentially a toxin into the human body, as it is not a traditional vaccine.

The speaker presents findings that show the spike protein from the COVID-19 vaccine is produced not only in the deltoid muscles where it is injected, but also in various organs. They provide examples of the spike protein being strongly expressed in the testes of a 28-year-old man who died after vaccination, leading to a decrease in spermatocytes. They also mention a similar expression in the testes of an older man. The speaker concludes with a personal comment, stating that if they were a woman of fertile age, they would be hesitant to plan motherhood with a vaccinated man due to the concerning findings.

The mRNA COVID-19 vaccine delivers instructions for creating spike proteins, which then triggers an immune response. The vaccine and spike protein are said to break down and disappear within days, leaving no trace and not affecting DNA. The vaccine is taken up at the injection site and quickly metabolized. However, an Australian Therapeutic Goods Administration document indicates the vaccine distributes throughout the body, including adipose tissue, adrenal glands, and the brain. There was allegedly no data on how quickly the mRNA degrades. Research indicates vaccine mRNA can be detected up to 14-15 days post-vaccination in some individuals. A rare post-vaccination syndrome (PVS) is associated with chronic conditions and elevated spike protein levels up to 709 days post-vaccination, even without detectable SARS-CoV-2 infection. One hypothesis suggests that the mRNA may reverse transcribe and integrate into DNA, causing continuous spike protein production and potentially leading to T cell exhaustion. The possibility of germline transfer and long-term health consequences is raised.

They examined tissues for spike and nucleocapsid proteins. Spike proteins are targeted by vaccines, while nucleocapsid proteins are not. In a patient positive for SARS-CoV-2, spike proteins were found in respiratory secretions, but nucleocapsid proteins were not. In an autopsy of a vaccinated patient who was not tested for SARS-CoV-2, spike proteins were present in the brain, but no nucleocapsid proteins were detected. The absence of nucleocapsid proteins in the brain is unexplained.

The speaker presents findings that indicate the spike protein from the COVID-19 vaccine is produced not only in the deltoid muscles but also in various organs. They show images of the testes in a 28-year-old man who died 140 days after vaccination, revealing strong expression of the spike protein in the spermatogenic organ. Similar results are observed in an older man. The speaker concludes by expressing personal concern about the implications of these images.

Pfizer did not use the actual spike mRNA; a luciferase reporter mRNA in the same lipid nanoparticles tracked biodistribution in rodents. After injection, most mRNA remained at the injection site, but notable levels were detected in the liver; limitations may underestimate low-level distributions, yet components are not confined to the injection site. Moderna did not perform a dedicated biodistribution study with the COVID mRNA; data came from a surrogate CMV mRNA (mRNA-sixteen 47) in the same lipid nanoparticle. In rats, high levels at the injection site and in draining lymph nodes, spleen, eye, and liver; lower levels in heart, lungs, testes, and brain, with the mRNA crossing the blood brain barrier. In humans, vaccine mRNA and its spike protein have been detected across blood, lymph nodes, heart, and brain, with persistence lasting weeks to months and reportedly seven zero six days post vaccination.

We could have answers soon by conducting immunohistochemical staining on tumors for viral proteins. A 2020 study found spike protein in hearts and tissues but not in cancers. Post-vaccine rollout, spike protein was found in cancers, hinting at vaccine involvement. Staining tumors on a large scale could reveal more. However, this is unlikely due to the lucrative mRNA vaccine industry, with plans to produce millions of doses. Connecting mRNA vaccines to cancer could threaten this industry's profits.